Adenovirus-mediated transfer of tissue-type plasminogen activator gene to human endothelial cells

Surgery

Volumn 122, Issue 1, 1997, Pages 91-100

  Sugawara, Yasuhiko ^b   Sakata, Yoichi ^b   Minowada, Seiji ^b   Hamada, Hirofumi ^b   Yoshida, Yoko ^b   Sato, Osamu ^b   Deguchi, Jun O ^b   Kimura, Hideo ^b   Namba, Toshiyuki ^b   Makuuchi, Masatoshi ^b   Miyata, Tetsuro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 12644273806     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90269-5     Document Type: Article

References (50)

1. Stansby G, Berwanger C, Shukla N, Hamilton G. Endothelial cell seeding of vascular grafts: status and prospects. Cardiovasc Surg 1994;2:543-8.
2. Li JM, Menconi MJ, Wheeler HB, Rohrer MJ, Anderson FA Jr, Cutler BS. Experimental femoral vein reconstruction with expanded polytetrafluoroethylene grafts seeded with endothelial cells. Cardiovasc Surg 1993;1:362-8.
3. Sato O, Tada Y, Takagi A. The biologic fate of Dacron double velour prostheses - a clinicopathological study. Jpn J Surg 1989;19:301-11.
4. Sauvage LR, Berger KE, Wood SJ, Yates SG II, Smith JC, Mansfield PB. Interspecies healing of porous arterial prostheses. Arch Surg 1974;109:698-705.
5. Poder TJ, Currriden SA, Loskutoff DJ. The fibrinolytic system of endothelial cells. In: Ryan US, editor. Endothelial cells. Boca Raton: CRC Press; 1988. p 127-48.
6. Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978;84:498-504.
7. Jensen N, Brunkwall J, Fält K, Lindblad B, Bergqvist D. Prostacyclin is produced from endothelial cell - seeded grafts: an experimental study in sheep. Eur J Vasc Surg 1992;6:499-504.
8. Budd JS, Allen K, Hartley J, Walsh A, James RL, Bell PF. Prostacyclin production from seeded prosthetic vascular grafts. Br J Surg 1992;79:1151-3.
9. Li JM, Menconi M, Wheeler HB, Rohrer MJ, Klassen VA, Ansell JE, et al. Precoating expanded polytetrafluoroethylene grafts alters production of endothelial cell - derived thrombomodulators. J Vasc Surg 1992;15:1010-7.
10. Herring M, Gardner A, Glover J. Seeding human arterial prostheses with mechanically derived endothelium. J Vasc Surg 1984;1:279-89.
11. Herring MB, Compton RS, LeGrand DR, Gardner AL, Madison DL, Glover JL. Endothelial seeding of polytetrafluoroethylene popliteal bypasses. J Vasc Surg 1987;6:114-8.
12. Örtenwall P, Wadenvik H, Kutti J, Risberg B. Reduction in deposition of indium 111-labeled platelets after autologous endothelial cell seeding of Dacron aortic bifurcation grafts in humans: a preliminary report. J Vasc Surg 1987;6:17-25.
13. Zilla P, Fascol R, Deutsch M, Fischlein T, Minar E, Hammerle A, et al. Endothelial cell seeding of polytetrafluoroethylene vascular grafts in humans: a preliminary report. J Vasc Surg 1987;6:535-41.
14. Fasol R, Zilla P, Deutsch M, Grimm M, Fischlein T, Laufer G. Human endothelial cell seeding: evaluation of its effectiveness by platelet parameters after one year. J Vasc Surg 1989;9:432-6.
15. Zilla P, Deutsch M, Meinhart J, Puschmann R, Eberl T, Minar E, et al. Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg 1994;19:540-8.
16. Jensen N, Lindblad B, Bergqvist D. Endothelial cell seeded dacron aortobifurcated grafts: platelet deposition and long-term follow-up. J Cardiovasc Surg 1994;35:425-9.
17. Dichek DA. Retroviral vector-mediated gene transfer into endothelial cells. Molecular Biology & Medicine 1991;8:257-66.
18. Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation 1989;80:1347-53.
19. Flugelman MY, Virmani R, Leon MB, Bowman RL, Dichek DA. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circ Res 1992;70:348-54.
20. Shayani V, Newman KD, Dichek DA. Optimization of recombinant t-PA secretion from seeded vascular grafts. J Surg Res 1994;57:495-504.
21. Ekhterae D, Stanley JC. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells. J Vasc Surg 1995;21:953-62.
22. Dunn PF, Newman KD, Jones M, Yamada I, Shayani V, Virmani R, et al. Seeding of vascular grafts with genetically modified endothelial cells: secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo. Circulation 1996;93:1439-46.
23. Nakamura Y, Wakimoto H, Abe J, Kanegae Y, Saito I, Aoyagi M, et al. Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2. Cancer Res 1994;54:5757-60.
24. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996;93:1320-4.
25. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193-9.
26. Sanes JR, Rubenstein JL, Nicolas JF. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 1986;5:3133-42.
27. Libby P, Birinyi LK. The dynamic nature of vascular endothelial cell functions. In: Zilla P, Deutch M, editors. Endothelialization of vascular grafts. Basel: Karger; 1987. p 80-99.
28. Birinyi LK, Warner SJC, Salomon RN, Callow AD, Libby P. Observations on human smooth muscle cell cultures from hyperplastic lesions of prosthetic bypass grafts: production of a platelet-derived growth factor-like mitogen and expression of a gene for a platelet derived growth factor receptor - a preliminary study. J Vasc Surg 1989;10:157-65.
29. Miyata T, Conte MS, Trudell LA, Mason D, Whittemore AD, Birinyi LK. Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts. J Surg Res 1991;50:485-93.
30. Kadletz M, Moser R, Preiss P, Deutsch M, Zilla P, Fascol R. In vitro lining of fibronectin coated PTFE grafts with cryopreserved saphenous vein endothelial cells. Thorac Cardiovasc Surg 1987;35:143-7.
31. Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981;256:7035-41.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
33. Wakabayashi K, Sakata Y, Aoki N. Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. J Biol Chem 1986;261:11097-105.
34. Levin EG, Loskutoff DJ. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 1982;94:631-6.
35. Sakata Y, Okada M, Noro A, Matsuda M. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells. J Biol Chem 1988;263:1960-9.
36. Friedmann T. Progress toward human gene therapy. Science 1989;244:1275-81.
37. Kanegae Y, Makimura M, Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 1994;47:157-66.
38. Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 1993;361:647-50.
39. Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford PLD, Perricaudet M, et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993;259:988-90.
40. Rich DP, Couture LA, Cardoza LM, Guiggio VM, Armentano D, Espino PC, et al. Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther 1993;4:461-76.
41. Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993;75:207-16.
42. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993;3:187-9.
43. Akli S, Caillaud C, Vigne E, Stratford Perricaudet LD, Poenaru L. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 1993;3:224-8.
44. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 1993;3:187-9.
45. Bassin RH, Tuttle N, Fischinger PJ. Rapid cell culture assay technic for murine leukaemia viruses. Nature 1971;229:564-6.
46. Simon RH, Engelhardt JF, Yang Y, Zepeda M, Weber PS, Grossman M, et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther 1993;4:771-80.
47. Davidson JT III, Callis JT. Arterial reconstruction of vessels in the foot and ankle. Ann Surg 1993;217:699-708.
48. Quinones Baldrich WJ, Colburn MD, Ahn SS, Gelabert HA, Moore WS. Very distal bypass for salvage of the severely ischemic extremity. Am J Surg 1993;166:117-23.
49. Yang Y, Nunes FA, Berencsi K, Gonczol E, Engelhardt JF, Wilson JM. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet 1994;7:362-9.
50. Kawai Y, Matsumoto Y, Watanabe K, Yamamoto H, Satoh K, Nurata M, et al. Hemodynamic forces modulate the effects of cytokines on fibrinolytic activity of endothelial cells. Blood 1996;87:2314-21.